Combined evaluation of postoperative serum levels of carcinoembryonic antigen less than or equal to 2.5 ng/ml and absence of vascular invasion may predict no recurrence of stage i adenocarcinoma lung cancer

Journal of Thoracic Oncology

Volumn 3, Issue 12, 2008, Pages 1416-1420

  Kashiwabara, Kosuke ^a,b   Saeki, Syoh ^a   Sasaki, Ji Ichiro ^a   Nomura, Masanobu ^a   Kohrogi, Hirotsugu ^a  

^a KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

Author keywords

Adjuvant chemotherapy; Cox proportional hazards model; Predictors for postoperative recurrence; Receiver operating characteristics (ROC) curve; Uracil tegafur (UFT)

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TECHNETIUM TIN COLLOID TC 99M; UFT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CONCENTRATION (PARAMETERS); FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG CANCER; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; BLOOD; EVALUATION; LUNG RESECTION; LUNG TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; POSTOPERATIVE PERIOD; PROGNOSIS; ROC CURVE; TREATMENT OUTCOME; TUMOR RECURRENCE; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PNEUMONECTOMY; POSTOPERATIVE PERIOD; PROGNOSIS; ROC CURVE; TREATMENT OUTCOME;

EID: 61449494426     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31818dda85     Document Type: Article

References (26)

1. Alberts WM. Diagnosis and managements of lung cancer executive summary. ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:1S-19S.
2. Kato H, Ichinose Y, Ohta M, et al.; Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004;350:1713-1721.
3. Hamada C, Tanaka F, Ohta M, et al. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. J Clin Oncol 2005;23:4999-5006.
4. Tsuchiya T, Akamine S, Muraoka M, et al. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer 2007;56:341-348.
5. The American Thoracic Society and the European Respiratory Society. Pretreatment evaluation of non-small cell lung cancer. Am J Respir Crit Care Med 1997;156:320-332.
6. Buucheri G, Ferringno D. Identifying patients at risk of early postoper- ative recurrence of lung cancer: a new use of the old CEA test. Ann Thorac Surg 2003;75:973-980.
7. Muley T, Dienemann H, Ebert W. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC. Anticancer Res 2003;23:4085-4093.
8. Sakao Y, Tomimitsu S, Takeda Y, et al. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma. Eur J Cardiothorac Surg 2004;25:520-522.
9. Yoshino I, Ichinose Y, Nagashima A, et al.; Kyushu Lung Cancer Surgery Cooperative Group. Clinical characterization of node-negative lung adenocarcinoma: results of a prospective investigation. J Thorac Oncol 2006;1:825-831.
10. Hsu WH, Huang CS, Hsu HS, et al. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small cell lung cancer. Ann Thorac Surg 2007;83:419-424.
11. Stevens DP, Mackay IR. Increased carcinoembryonic antigen in heavy cigarette smokers. Lancet 1973;2:1238-1239.
12. Kashiwabara K, Nakamura H, Kiguchi T, et al. Chronological change of respiratory function in smokers with elevated serum carcinoembryonic antigen levels. Clin Chim Acta 1998;276:179-186.
13. Kashiwabara K, Nakamura H, Yokoi T. Chronological change of serum carcinoembryonic antigen (CEA) concentrations and pulmonary function data after cessation of smoking in subjects with smoking-associated CEA abnormality. Clin Chim Acta 2001;303:25-32.
14. Okada M, Nishio W, Sakamoto T, et al. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Ann Thorac Surg 2004;78: 1004-1010.
15. Sawabata N, Ohta M, Takeda S, et al. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 2002;74:174-179.
16. Tomita M, Matsuzaki Y, Shimizu T, et al. Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels. Thorac Cardiovasc Surg 2005;53:300-304.
17. Nonaka M, Kataoka D, Yamamoto S, et al. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma. Ann Thorac Cardiovasc Surg 2004;10:281-284.
18. Okada M, Nisio W, Sakamoto T, et al. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. Ann Thorac Surg 2004;78:216-221.
19. Nomori H, Ikeda K, Mori T, et al. Sentinel node navigation segmentectomy for clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2007;133:780-785.
20. Nomori H, Iwatani K, Kobayashi H, et al. Omission of mediastinal lymph node dissection in lung cancer: its techniques and diagnostic procedures. Ann Thorac Cardiovasc Surg 2006;12:83-88.
21. Yoshimasu T, Miyoshi S, Maebeya S, et al. Analysis of the early postoperative serum carcinoembryonic antigen time-course as a prognostic tool for bronchogenic carcinoma. Cancer 1997;79:1533-1540.
22. Yoshimasu T, Kokawa Y, Oura S, et al. Time course of carcinoembryonic antigen after resection of lung cancer: a predictor of recurrence. Cancer Sci 2003;94:741-744.
23. Ogawa J, Tsurumi T, Yamada S, et al. Blood vessel invasion and expression of sialyl Lewisx and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence. Cancer 1994 15;73:1177-1183.
24. Ichinose Y, Yano T, Yokoyama H, et al. The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer. A potential risk of limited resection. J Thorac Cardiovasc Surg 1994;108:684-686.
25. Kessler R, Gasser B, Massard G, et al. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg 1996;62:1489-1493.
26. Tsuchiya T, Hashizume S, Akamine S, et al. Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer. Chest 2007;132:170-177.